Reference
Miranda KW, et al. Targeted Fibroblast Growth Factor Receptor (FGFR) Inhibition in Recurrent, Metastatic Anal Carcinoma: A Case Report. Clinical Colorectal Cancer 21: 272-275, No. 3, Sep 2022. Available from: URL: http://doi.org/10.1016/j.clcc.2022.01.001
Rights and permissions
About this article
Cite this article
Antineoplastics/folinic acid. Reactions Weekly 1927, 81 (2022). https://doi.org/10.1007/s40278-022-24817-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-24817-6